Top Stock Movers Today — September 15, 2026: Why RETO, VEEA, NWGL, PDSB & IPW Surged
Five stocks dominated the September 15, 2026 close: RETO +845%, VEEA +149% on a $750M merger, PDSB +47% on a PIPE deal, NWGL +47%, and IPW +35%. Here's what drove each move.
RETO — ReTo Eco-Solutions, Inc. (+845.4%)
ReTo Eco-Solutions closed at $3.41, an extraordinary +845.4% single-session gain, on volume of 283,968,350 shares — nearly 19.5× its 20-day average of 14,565,561. For a company with a market cap of just $12.0 million coming into today, that kind of volume is almost incomprehensible and flags extreme speculative interest.
Why it moved: No researched catalyst or news headline is on file for this move. With no identifiable fundamental driver, this looks like a pure momentum and technical event, likely amplified by its tiny size. When a micro-cap with a $12M market cap trades nearly 284 million shares in a single session, price can move violently on even modest dollar flows — a dynamic sometimes called a "low-float rocket," where limited supply of tradeable shares meets a surge of buy orders.
RETO's short interest stands at just 18,592 shares with 0.0 days to cover, so a traditional short squeeze — where short sellers are forced to buy back shares, driving the price higher — is not the story here. The squeeze score of 28/100 confirms this. The technical picture shows a bullish belt hold candlestick (a candle that opens at or near its low and closes near its high, signaling a potential reversal of downside pressure), an RSI of 72 (in overbought territory), and a bullish moving-average stack. StockSetups assigned a conviction score of 57/100 and a grade of C — reflecting the technically constructive read tempered by the lack of a clear fundamental driver.
Moves like this almost always retrace sharply. With no known catalyst, chasing a name that is up over 800% in a single session carries extreme risk.
VEEA — VEEA INC. (+149.3%)
VEEA Inc. closed at $5.71, up +149.3% on the session, hitting a 52-week high on volume of 190,347,292 shares — roughly 14.3× its 20-day average of 13,263,550. VEEA was also the standout name in this morning's premarket session and appeared in yesterday's after-close recap as well — a rare back-to-back headline mover.
Why it moved: The catalyst is clear and well-documented. On September 14, Veea Inc. and NovaGen Group signed a term sheet for a $750 million business combination to launch what the companies described as an "Edge AI-Powered Global Health Platform" under the name NovaGen Health Networks (per Quiver Quantitative, Yahoo Finance, and Finimize). A merger announcement of this scale — pairing an edge-computing company with a health platform at a $750M proposed valuation — is a textbook binary catalyst for a small-cap stock.
The gap is the tell: VEEA opened with a +88.6% gap at the open (a gap is when a stock opens meaningfully above or below the prior day's close, leaving a price void on the chart). It never looked back, closing up 149% and at a fresh 52-week high. With a free float of just 43.5% (meaning less than half of all shares are freely tradeable by the public), even moderate buying pressure can produce outsized price moves — see our gap-and-go setup explainer for how traders approach these situations.
StockSetups flagged VEEA with its highest possible marks: RSI 95, ADX 59 (indicating a very strong trend), an RS rating of 99, technical rank of 100, a conviction score of 92/100, and a grade of A+ — the strongest reading in today's mover list. The squeeze score of 46/100 is modest, and with 671,095 shares short and 2.8 days to cover, there is a secondary squeeze component, but the merger news is the primary driver. With two prior 8-K filings in August signaling activity, sophisticated traders who read the SEC filings may have been positioned ahead of today's announcement.
NWGL — CL Workshop Group Ltd (+46.7%)
CL Workshop Group closed at $1.77, up +46.7%, hitting a 52-week high on volume of 21,414,223 shares — approximately 8.6× its 20-day average of 2,495,782. The company operates in the Energy sector with a market cap of $29.4 million.
Why it moved: No news headline or researched catalyst is on file for NWGL. The most recent SEC filings — a pair of 6-Ks filed in August reporting foreign events, a 424B3 resale prospectus, and an F-1/A amendment (consistent with a company that recently completed or is completing an IPO process) — offer no obvious trigger for today's move. With no clear fundamental driver, this appears to be a technical and momentum-driven event.
NWGL's squeeze score is 53/100 — the highest among today's five movers — with 744,431 shares short and 0.7 days to cover. "Days to cover" refers to how many days of average trading volume it would take for all short sellers to buy back their shares; a figure below one means shorts could theoretically be squeezed out very quickly if buying pressure intensifies. Combined with a fresh 52-week high and a very strong ADX of 59 (signaling a powerful trend), this setup has the hallmarks of a momentum-driven squeeze extension.
StockSetups rated NWGL with a conviction score of 77/100 and a grade of A, with a trend-template score of 5 — one of the cleaner technical reads in today's group. The mixed MA stack is the one caveat. As always, approaching a stock that has gained nearly 47% in a single session without a confirmed catalyst demands extra caution.
PDSB — PDS Biotechnology Corp (+46.5%)
PDS Biotechnology Corp closed at $0.58, up +46.5%, on volume of 264,829,202 shares — nearly 5.9× its 20-day average of 44,708,356. The stock remains -59.1% off its 52-week high, signaling that today's rally follows a significant longer-term downtrend. Market cap stands at $32.7 million.
Why it moved: The catalyst is a major capital and leadership event. On September 14, PDS Biotech announced the initial closing of up to $22.3 million in PIPE financing (a PIPE — Private Investment in Public Equity — is when institutional or accredited investors buy newly issued shares directly from a company, often at a negotiated price, giving the company quick access to capital). The deal was led by Nant Capital, the investment vehicle of prominent oncologist and biotech billionaire Dr. Patrick Soon-Shiong, who simultaneously joined the PDS Biotechnology board of directors (per Yahoo Finance, Stock Titan, and Quiver Quantitative). PDS also retired existing debt as part of the transaction. The $11.3 million initial closing of the deal was confirmed.
The combination of a high-profile investor endorsement, board appointment, debt retirement, and fresh capital is a powerful trifecta for a small biotech that has been under pressure. PDSB also appeared in our September 8 premarket recap, suggesting it has been on traders' radars.
Technically, the picture is mixed. The stock gapped up +23.2% at the open and sustained gains through the close. RSI reached 72 (overbought) with ADX at 48 (strong trend), but the MA stack is mixed and the trend-template score is just 2. StockSetups graded PDSB a D with a conviction score of 38/100 — reflecting the weak longer-term technical structure despite today's strong one-day move. The September 14 8-K flagging a material agreement termination, alongside a prior dilution filing on September 8, are risk factors traders should read carefully. Reddit buzz placed PDSB at rank #88 on r/all-stocks with 4 mentions — modest retail attention.
IPW — iPower Inc. (+34.7%)
iPower Inc. closed at $2.60, up +34.7%, on volume of 69,003,684 shares — roughly 19.2× its 20-day average of 3,589,729. The Consumer Discretionary company carries a market cap of just $13.8 million and sits a stark -91.1% below its 52-week high — meaning the stock has been in severe long-term decline before today's jump.
Why it moved: No news headline or researched catalyst is on file. The SEC filing history shows a pair of S-1/A amendments (typically related to a registration or offering process) and a DEF 14A proxy filing, but nothing that explains a single-session surge of this magnitude. HRT Financial LP, a quantitative trading firm, disclosed a Form 4 purchase of 17,944 shares (~$37K) back on July 6 — a very small insider purchase that is not likely to be the trigger here.
With no clear catalyst, this looks like a momentum and volume event. IPW's free float is 52.1% — meaning just over half of shares are freely tradeable — and the volume surge of 19× average is the most striking data point. Short interest is minimal at 46,595 shares (0.2 days to cover), ruling out a squeeze as the driver. The StockSetups technical read shows an inverted hammer candlestick (a candle with a long upper wick and small body near the session's low — often a sign of selling pressure emerging after an intraday rally, a potential caution flag), RSI of 62, ADX of 22 (a weak trend), and a mixed MA stack. Conviction scored 38/100, grade D, trend-template 2 — the weakest technical profile of today's five movers.
The smart-money score of 26/100 and the largest disclosed stake of just 0.5% suggest limited institutional sponsorship. With no catalyst and a stock that remains nearly 91% off its highs, extreme caution is warranted.
The bottom line
Today's five biggest gainers — RETO (+845%), VEEA (+149%), NWGL (+47%), PDSB (+47%), and IPW (+35%) — span industrials, technology, energy, healthcare, and consumer discretionary, but share one trait: extreme one-day volatility far beyond what most diversified portfolios can comfortably handle.
VEEA had the clearest, most consequential catalyst (the $750M NovaGen merger announcement) and the strongest technical setup. PDSB had a credible, documented fundamental driver in the Nant Capital PIPE and Dr. Soon-Shiong's board appointment. NWGL, RETO, and IPW moved sharply on high relative volume with no confirmed news — the kind of action that can reverse just as fast as it appeared.
A few honest reminders before you act on anything here:
- Big one-day gainers frequently give back much of their move in the sessions that follow. Chasing a stock after it has already surged 50%, 150%, or 845% puts you at the back of the line.
- Chart patterns, squeezes, and momentum signals all fail — sometimes immediately. A high conviction score or a bullish candlestick is not a guarantee of further gains.
- Low-float, micro-cap stocks (like several on today's list) can move violently in both directions on thin liquidity. Position sizing and stop-losses are not optional.
- This recap is educational only — it is not financial advice or a recommendation to buy or sell any security. Always do your own research.
StockSetups scans the full ~12,300-stock US universe after every close, detecting chart patterns confirmed by candlesticks and scoring each setup for conviction, short-squeeze potential, relative strength, and smart-money activity — so you always know where today's biggest movers stood technically before the session began. Check back after tomorrow's close for the next recap.
Frequently asked questions
Why is RETO stock up today?
RETO surged +845.4% on September 15, 2026, on volume nearly 20 times its 20-day average. No confirmed news catalyst is on file; the move appears to be momentum- and volume-driven in a very small micro-cap ($12M market cap). With no short-squeeze component and no fundamental driver, the move carries extreme reversal risk.
Why is VEEA stock up today?
VEEA jumped +149.3% after Veea Inc. and NovaGen Group signed a term sheet on September 14 for a $750 million business combination to launch an Edge AI-Powered Global Health Platform. The stock gapped up 88.6% at the open and hit a 52-week high. StockSetups rated it A+ with a 92/100 conviction score.
Why is PDSB stock up today?
PDS Biotechnology surged +46.5% after announcing an initial closing of up to $22.3 million in PIPE financing led by Nant Capital, along with the appointment of Dr. Patrick Soon-Shiong (a prominent oncologist and biotech investor) to its board. The company also retired existing debt as part of the deal.
What is a low-float stock and why does it move so much?
The 'float' is the number of shares freely available for the public to trade. A low-float stock has relatively few tradeable shares, so even a moderate surge in buying demand can cause an outsized price move — because there isn't much supply to absorb it. Low-float stocks can also drop just as fast when selling kicks in.
What is a PIPE deal in biotech?
PIPE stands for Private Investment in Public Equity. A company sells newly issued shares directly to institutional or accredited investors at a negotiated price, bypassing the open market. It's a fast way to raise capital but can be dilutive to existing shareholders. For PDSB, the PIPE was led by Nant Capital and raised $11.3 million in its initial closing.
Produced with AI assistance and published under the StockSetups editorial guidelines.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →